Abstract
This review provides a comprehensive understanding of magnetoelectric (ME) nanocomposite, cobalt ferrite–barium titanate (CFO–BTO) as a potential candidate for targeting specific cells. The synthesized core–shell material uses strain-mediated coupling between magnetostrictive and piezoelectric material. CFO–BTO has the competitive advantage of a high ME coefficient and is biocompatible. The shape and size play a pivotal role in passive drug delivery due to the enhanced permeability and retention effect at tumor sites. Surfactants can also enhance drug absorption and influence the interaction with nanoparticle composite. A comparison between external magnetic field–frequency parameters to navigate the ME nanoparticle and trigger release of the drug at site is also reviewed. Coating the nanoparticles with a layer of surfactant can reduce the threshold external magnetic field for navigation and triggering of drug particle release, making the prospect viable for clinical studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
